Treatment Registry
TR-0296 ActiveRecorded September 2026Last verified September 2026

Unspecified GLP-1

Sold by Factor Health MD · Injection, vial · every unspecified glp-1 record

Recorded initial charges

Initial payment · 3-month plan

$450

Monthly equivalent

$150

initial payment (3-month medication term), including required fees on record. The monthly equivalent is not a monthly bill. It combines the advertised medication rate with any recorded monthly membership and excludes one-time and annual fees. Renewal charges are not established by that figure. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Liraglutide -- Quarterly (3-month) · recorded upfront charge for 3 months$450

Added from the figures recorded below.

Price

TermPer monthCharged today
Liraglutide -- Quarterly (3-month)

“Injectable – $150/month $450 for 3-month supply Up to 1.8mg MAX Dose”

Per month$150Charged today$450
Price sources
Visit Factor Health MD

We earn nothing from this link. It opens Factor Health MD's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

StatesNot disclosed
PrescriberLive visit
CancellationIf you cancel your membership within 30 days of your initial enrollment, you are eligible for a full refund of your first month’s fee.
MembershipNot disclosed
Consult feeNone. “Free online consultation”

Not yet checked: pharmacy.

Recorded from factorhealthmd.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — The `unspecified GLP-1` entry above is specifically Liraglutide, named as such on the site -- it doesn't fit any of the `drug` enum's more specific values (semaglutide/tirzepatide, compounded or brand). All prices are cash prices; the FAQ and product pages repeatedly state 'No insurance required' and no insurance-billed price appears anywhere. Semaglutide Plus and Tirzepatide Plus are explicitly flat-rate, dose-inclusive prices ('Your price will not increase' regardless of dose) and the FAQ confirms medication is included in the displayed program fee ('The program fees displayed on our website include medication costs'), so there is no separate membership fee to record -- membership.found is false. State coverage: the terms of service only say services are available in 'select states' and circularly point back to 'the Factor Health MD website' for a list that was not found on any fetched page.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0296
Medication category
unspecified GLP-1
Readings
2

Related records

Other records from Factor Health MD

All Factor Health MD programs and terms

Unspecified GLP-1 at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 73 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Factor Health MD — unspecified GLP-1 (TR-0296). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0296

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.